Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-01

Clinical Trial Update: A Possible Therapeutic Role for Adenosine During Inflammation [Phase 1]

View source ↗

Summary

A Phase 1 study evaluates adenosine as a potential therapy to modulate inflammation in endotoxemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adenosine (Adenosine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Endotoxemia | Phase 1 | Status: COMPLETED